Delivery Order SPE2DB22D3016-SPE2DB26FAAQ9
- Not listed
- The Defense Logistics Agency awarded a $12,015.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp on April 8, 2025, for the supply of Tasigna 150 mg capsules (28-count units). This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order is scheduled for completion by April 29, 2025, with performance at the...
- The Defense Logistics Agency awarded a delivery order valued at $6,007.90 to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count package) on September 22, 2025, with completion expected by October 14, 2025. This firm fixed-price, competitively awarded delivery order represents a non-set-aside procurement and is performed from the vendor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Tasigna 150 mg capsules (quantity: 28-count packages) under a firm fixed-price contract. This non-set-aside competitive award carries a ceiling value of $12,015.80 and an ultimate completion date of October 21, 2025. The delivery order is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $6,007.90 to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count packaging) with a firm fixed price structure. This non-set-aside contract was awarded on July 30, 2025, with an ultimate completion date of August 20, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a single transaction under the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,015.80 to AmerisourceBergen Drug Corp for the supply of Tasigna 150 mg capsules (28-count units) under a firm fixed price contract. The award was made on August 12, 2025, with an ultimate completion date of September 3, 2025, and does not utilize a set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a $18,023.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Tasigna 150 mg capsules (28-count units) on September 28, 2025, with an ultimate completion date of October 20, 2025. This non-set-aside competitive award is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $12,015.80 to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count units) on September 24, 2025, with completion targeted for October 16, 2025. This firm fixed-price, non-set-aside contract represents a pharmaceutical supply delivery under the company's existing relationship with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Tasigna 50 mg capsules in a quantity of 120 units. This is a firm fixed-price delivery order with a ceiling value of $11,638.02 and an ultimate completion date of September 23, 2025. The contract was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,015.80 on October 21, 2025, for the supply of Tasigna 150 mg capsules (28-count units). This firm fixed-price, non-set-aside contract is scheduled for completion by November 12, 2025, with performance taking place at the contractor's corporate office in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count) valued at $6,007.90 under a firm fixed-price contract type. The award, issued on August 7, 2025, with an ultimate completion date of August 28, 2025, represents a non-competitive delivery against AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be supplied to the place of performance in Conshohocken,...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB26FAAQ9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,015.80 to AmerisourceBergen Drug Corp for Tasigna 150 mg capsules (28-count units) on October 27, 2025, with completion targeted for November 18, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's Conshohocken, Pennsylvania location. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant federal contract portfolio supplying medications and medical supplies across multiple therapeutic domains to military and veteran healthcare systems. As a critical vendor in the Defense Logistics Agency's Medical Supply Chain, the company has demonstrated consistent capability to fulfill federal pharmaceutical procurement requirements through open competition. This specific order for Tasigna, a specialized oncology medication, exemplifies the breadth of therapeutic products the company provides through its prime vendor relationship with DLA, enabling supply of brand-name and generic drugs, vaccines, and medical devices to support Defense Health Agency operations and other federal healthcare customers worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.0k | 10/27/25 |